» Articles » PMID: 27270764

Enhanced Expression of Unique Gangliosides with GM2-determinant in Human Uterine Cervical Carcinoma-derived Cell Lines

Overview
Journal Glycoconj J
Publisher Springer
Date 2016 Jun 9
PMID 27270764
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Monoclonal antibody YHD-06 generated by immunization with GM2 reacted with gangliosides with GM2-determinant, i.e., GM2, GalNAc-GM1b and GalNAc-GD1a, among which GalNAc-GD1a was characterized as an antigen of autoimmune peripheral neuropathies including Guillain-Barré syndrome. When glycolipids were examined by TLC-immunostaining with YHD-06 in seven human cervical carcinoma-derived cell lines, GM2 was found in all cell lines, amounting to 15.5 % to 57.5 % of total gangliosides. Whereas GalNAc-GD1a was present in three cell lines, amounting to 5.4-17.5 % of total gangliosides, and GalNAc-GM1b in four cell lines in amounts of less than 2 %. The elevated amounts of gangliosides with GM2 determinant were closely correlated with the relative intensities of gene expression of GalNAc transferase, this being characteristic of cervical carcinoma-derived cells. However, in tissues from patients with several histological types of cervical carcinomas, GM3 was ubiquitously expressed in amounts of more than 66 % of total gangliosides, GM2 was expressed in only five of 15 tissues, and both GalNAc-GM1b and GalNAc-GD1a were not even detected in trace amounts. Since GM1 was detected in all tissues in amounts of less than 0.06 μg/mg dried tissue, all cervical carcinoma tissues were revealed to exhibit GM2 synthesis, indicating that enhanced synthesis of gangliosides with GM2 determinant is a characteristic of cultivated cells in vitro. Similarly, although I(3)SO3-GalCer was not present in the squamous cell carcinoma (SCC) tissues, SCC-derived cells selectively expressed II(3)SO3-LacCer. Since enhanced synthesis of GM2 has been reported in SV-40 virus-transfected fibroblasts, papilloma virus might be involved in the expression of GM2 in cervical carcinoma-derived cells.

Citing Articles

Reduced expression of gangliosides with GM2-determinant in cervical carcinoma-derived cells after subcutaneous transplantation into nude mice.

Tanaka K, Murakami I, Mikami M, Aoki D, Iwamori M Hum Cell. 2023; 36(3):1199-1203.

PMID: 36932279 PMC: 10110664. DOI: 10.1007/s13577-023-00864-z.


Novel Thieno [2,3-]pyridine Anticancer Compound Lowers Cancer Stem Cell Fraction Inducing Shift of Lipid to Glucose Metabolism.

Pervan M, Marijan S, Markotic A, Pilkington L, Haverkate N, Barker D Int J Mol Sci. 2022; 23(19).

PMID: 36232754 PMC: 9569594. DOI: 10.3390/ijms231911457.


Characterization of a novel glycolipid with a difucosylated H-antigen in human blood group O erythrocytes with monoclonal antibody HMMC-1 and its detection in human uterine cervical carcinoma tissues.

Tanaka K, Suzuki A, Aoki D, Iwamori M Glycoconj J. 2019; 36(3):219-226.

PMID: 31098851 DOI: 10.1007/s10719-019-09873-3.

References
1.
Kiguchi K, Iwamori Y, Suzuki N, Kobayashi Y, Ishizuka B, Ishiwata I . Characteristic expression of globotriaosyl ceramide in human ovarian carcinoma-derived cells with anticancer drug resistance. Cancer Sci. 2006; 97(12):1321-6. PMC: 11159370. DOI: 10.1111/j.1349-7006.2006.00326.x. View

2.
Iwamori M, Kaido T, Iwamori Y, Ohta Y, Tsukamoto K, Kozaki S . Involvement of the C-terminal tail of Arthrobacter ureafaciens sialidase isoenzyme M in cleavage of the internal sialic acid of ganglioside GM1. J Biochem. 2005; 138(3):327-34. DOI: 10.1093/jb/mvi126. View

3.
Ault K . Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet. 2007; 369(9576):1861-1868. DOI: 10.1016/S0140-6736(07)60852-6. View

4.
Bevilacqua M, Stengelin S, Gimbrone Jr M, Seed B . Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science. 1989; 243(4895):1160-5. DOI: 10.1126/science.2466335. View

5.
Tiltman A . The pathology of cervical tumours. Best Pract Res Clin Obstet Gynaecol. 2005; 19(4):485-500. DOI: 10.1016/j.bpobgyn.2005.02.003. View